Patents by Inventor Shingo Shinagawa

Shingo Shinagawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody against mutant ?-actinin-4
    Patent number: 9644026
    Abstract: An antibody against mutant ?-actinin-4 having an amino acid sequence with at least one amino acid residue substitution in the region between position 245 and 263 in the amino acid sequence of ?-actinin-4, wherein the antibody recognizes all or a part of the substituted amino acid residue(s) in the region.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: May 9, 2017
    Assignees: TRANS GENIC INC., NATIONAL CANCER CENTER
    Inventors: Shingo Shinagawa, Kazunari Ito, Yoshimi Tokashiki, Tomoaki Miyamoto, Kazufumi Honda, Tesshi Yamada
  • ANTIBODY AGAINST MUTANT ALPHA-ACTININ-4
    Publication number: 20140248261
    Abstract: An antibody against mutant ?-actinin-4 having an amino acid sequence with at least one amino acid residue substitution in the region between position 245 and 263 in the amino acid sequence of ?-actinin-4, wherein the antibody recognizes all or a part of the substituted amino acid residue(s) in the region.
    Type: Application
    Filed: September 9, 2011
    Publication date: September 4, 2014
    Applicants: NATIONAL CANCER CENTER, TRANS GENIC INC.
    Inventors: Shingo Shinagawa, Kazunari Ito, Yoshimi Tokashiki, Tomoaki Miyamoto, Kazufumi Honda, Tesshi Yamada
  • High affinity anti-N,N-diacetylspermine monoclonal antibody
    Patent number: 7700741
    Abstract: The present invention provides an anti-diacetylspermine specific monoclonal antibody which satisfies a specific measuring condition in an immunoreaction system between a solid-phased diacetylspermine and the anti-diacetylspermine specific monoclonal antibody, wherein the immunoreaction system comprises a sample diacetylspermine or sample N1-acetylspermidine to inhibit the immunoreaction; and the specific measuring condition is that the 50% inhibition activity against the immunoreaction by the diacetylspermine in the sample is at least 1,000 times as much as the 50% inhibition activity against the immunoreaction by the N1-acetylspermidine in the sample.
    Type: Grant
    Filed: October 31, 2005
    Date of Patent: April 20, 2010
    Assignee: Trans Genic Inc.
    Inventors: Yusei Nagase, Shingo Shinagawa, Masao Kawakita, Kyoko Hiramatsu, Mika Ito, Yosuke Mizukami, Chiemi Minoda
  • HIGH AFFINITY ANTI-N1,N12-DIACETYLSPERMINE MONOCLONAL ANTIBODY
    Publication number: 20100093006
    Abstract: The present invention provides an anti-diacetylspermine specific monoclonal antibody which satisfies a specific measuring condition in an immunoreaction system between a solid-phased diacetylspermine and the anti-diacetylspermine specific monoclonal antibody, wherein the immunoreaction system comprises a sample diacetylspermine or sample N1-acetylspermidine to inhibit the immunoreaction; and the specific measuring condition is that the 50% inhibition activity against the immunoreaction by the diacetylspermine in the sample is at least 1,000 times as much as the 50% inhibition activity against the immunoreaction by the N1-acetylspermidine in the sample.
    Type: Application
    Filed: October 13, 2009
    Publication date: April 15, 2010
    Inventors: Yusei Nagase, Shingo Shinagawa, Masao Kawakita, Kyoko Hiramatsu, Mika Ito, Yosuke Mizukami, Chiemi Minoda
  • High affinity anti-N¹,N¹²-diacetylspermine monoclonal antibody
    Publication number: 20060166297
    Abstract: The present invention provides an anti-diacetylspermine specific monoclonal antibody which satisfies a specific measuring condition in an immunoreaction system between a solid-phased diacetylspermine and the anti-diacetylspermine specific monoclonal antibody, wherein the immunoreaction system comprises a sample diacetylspermine or sample N1-acetylspermidine to inhibit the immunoreaction; and the specific measuring condition is that the 50% inhibition activity against the immunoreaction by the diacetylspermine in the sample is at least 1,000 times as much as the 50% inhibition activity against the immunoreaction by the N1-acetylspermidine in the sample.
    Type: Application
    Filed: October 31, 2005
    Publication date: July 27, 2006
    Inventors: Yusei Nagase, Shingo Shinagawa, Masao Kawakita, Kyoko Hiramatsu, Mika Ito, Yosuke Mizukami, Chiemi Minoda